Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis in Lung Cancer

NCT05326906 is registered in ClinicalTrials.gov with Hunan Province Tumor Hospital as lead sponsor.

NCT NCT05326906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05326906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis in Lung Cancer
Lead sponsor
Hunan Province Tumor Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2018
Completion date
May 1, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer